A general look at female orgasm and anorgasmia

Sexual Health

Volumn 3, Issue 3, 2006, Pages 143-153

  Redelman, Margaret ^a  

^a Sydney Centre for Sexual and Relationship Therapy   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANDROFEME; ANDROGEN; ESTROGEN; PHOSPHODIESTERASE V INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; TESTOSTERONE; TIBOLONE;

ANDROGEN DEFICIENCY; ANORGASMIA; CLINICAL TRIAL; ETHNOLOGY; FEMALE SEXUAL DYSFUNCTION; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; MENTAL HEALTH; ORGASM; ORGASM DISORDER; PREVALENCE; REVIEW; SEXUAL AROUSAL; SEXUAL AROUSAL DISORDER; SEXUAL BEHAVIOR; SEXUAL DEVELOPMENT; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SEXUALITY; STATISTICAL SIGNIFICANCE;

COITUS; FEMALE; HUMANS; MENOPAUSE; ORGASM; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; VAGINA; WOMEN'S HEALTH;

EID: 33748290189     PISSN: 14485028     EISSN: None     Source Type: Journal    
DOI: 10.1071/SH06005     Document Type: Review

References (61)

1. Moynihan R. J Sex Med 2003; July 66-68.
2. Tiefer L, Hall M, Travis C. Beyond dysfunction: a new view of women's sexual problems. J Sex Marital Ther 2002; 28(s): 225-232.
3. Meston CM, Hull E, Levin RJ, Sipski M. Disorders of orgasm in women. J Sex Med 2004; 1: 66-8. doi: 10.1111/j.1743-6109.2004.10110.x
4. Hite S. The Hite Report. New York: Macmillan; 1976.
5. Spector IP, Carey MP. Incidence & prevalence of sexual dysfunctions: A critical review. Arch Sex Behav 1990; 19: 389-408. doi: 10.1007/BF01541933
6. Lloyd EA. The case of the female orgasm: bias in the science of evolution. Cambridge, MA: Harvard University Press; 2005.
7. Symons D. The evolution of human sexuality. Oxford, UK: Oxford University Press; 1979.
8. Komisaruk BR, Whipple B. The suppression of pain by genital stimulation in females. Annu Rev Sex Res 1996; 6: 151-84.
9. Kellogg-Spadt S. Demystifying female sexual response: the best is yet to come. In 'Program and abstracts of the National Association of Nurse Practitioners in Women's Health 7th Annual Conference; 13-16 October 2004; Chicago, IL'.
10. Masters EH, Johnson VE. Human sexual response. Boston, MA: Little Brown; 1966.
11. Ladas AK, Whipple B, Perry JD. The G-spot and other discoveries about human sexuality. New York: Holt, Rinehart & Winston; 1982.
12. Levin R. The G spot-reality or illusion? Sex Relationship Ther 2003; 18(1): 117-9. doi: 10.1080/1468199031000064487
13. O'Connell HE, Hutson JM, Anderson CR, Plenter RJ. Anatomical relationship between the urethra and clitoris. J Urology 1998; 159: 1892-7. doi: 10.1016/S0022-5347(01)63188-4
14. Kaplan KS. Hypoactive sexual desire. J Sex Marital Ther 1979; 3: 3-9.
15. Garde I, Lunde I. Female sexual behaviour - a study in a random sample of 40-year-old women. Maturitas 1980; 2: 240-55.
16. Schnarch DM. Constructing the sexual crucible - an integration of sexual and marital therapy. New York: Norton; 1991.
17. Basson R. Using a different model for female responses to address women's problematic low sexual desire. J Sex Marital Ther 2001a; 27(5): 395-403.
18. Basson R. Biopsychosocial models of women's sexual response: applications to the management of 'desire disorders'. Sex Relationship Ther 2003; 18(1): 107-115. doi: 10.1080/1468199031000061308
19. DSM-IV. Diagnostic and statistical manual of mental disorders (4th edn). Washington, DC: American Psychiatric Association; 1994.
20. Reinisch JM. The Kinsey Institute New Report on Sex. New York: The Kinsey Institute; 1990.
21. Laumann EO, Paik A, Rosen RC. Sexual dysfunctions in the United States: prevalence and predictors. JAMA 1999; 281: 537-44. doi: 10.1001/jama.281.6.537
22. Richters J, Rissel C. Doing it down under - the sexual lives of Australians. Sydney: Allen & Unwin; 2005.
23. Kinsey AC, Wardell BP, Martin CE. Sexual behaviour in the human female. New York: Pocket Books Inc.; 1965.
24. Hunt M. Sexual behaviour in the 1970's. New York: Dell Publishing Co.; 1974.
25. Tavris C, Sadd S. The redbook report on female sexuality. New York: Delacorte Press; 1975.
26. STRAW, NIH Consensus Development Program. State of Science Statement on Management of Menopause Related Symptoms. March 2005. (Bethesda, MD: National Institute of Health.)
27. Bachmann GA, Bancroft J, Braunstein G, Burger H, Davis S, Dennerstein L, Goldstein I, Guay A, Leiblum S, Lobo R, Notelovitz M, Rosen R. Female androgen insufficiency: The Princeton consensus statement on definition, classification and assessment. Fertil Steril 2002; 77(4): 660-5. doi: 10.1016/S0015-0282(02) 02969-2
28. Sarrel PM. Sexuality and menopause. Obstet Gynaecol 1990; 75: 26S-30S.
29. Berman JR, Goldstein I. Female sexual dysfunction. Urol Clin North Am 2001; 28: 405-16. doi: 10.1016/S0094-0143(05)70148-8
30. Park K, Goldstein I, Andry C, Siroky MB, Krane RJ, Azadzoi KM. Vasculogenic female sexual dysfunction: the hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. Int J Impot Res 1997; 9: 27-37. doi: 10.1038/sj.ijir.3900258
31. Berman L. Women too may benefit from Viagra. Presented at the American Urological Association Meeting, Atlanta, GA, 29 April-4 May 2000.
32. Rako S. Testosterone deficiency and supplementation for women: matters of sexuality and health. Psychiatry Annu 1999; 29: 23-6.
33. Santow G, Bracker M. Correlates of hysterectomy in Australia. Soc Sci Med 1992; 34: 929-42. doi: 10.1016/0277-9536(92)90261-N
34. Burger HG, Dudley EC, Cui JS, Dennerstein L, Hopper JL. A prospective longitudinal study of serum testosterone, dehydroepiandroosterone sulfate and sex hormone binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000; 85: 2832-8. doi: 10.1210/jc.85.8.2832
35. LoPiccolo J, Stock WE. Treatment of sexual dysfunction. J Consult Clin Psychol 1986; 54: 158-67. doi: 10.1037/0022-006X.54.2.158
36. Heiman JR, Meston CM. Empirically validated treatment for sexual dysfunction. Annu Rev Sex Res 1997; 8: 148-94.
37. Meston CM, Frolich PF. Update on female sexual function. Curr Opin Urol 2001; 11: 603-9. doi: 10.1097/00042307-200111000-00008
38. Heiman J, LoPicollo J. Becoming orgasmic: a sexual and personal growth program for women. New York: Prentice Hall; 1988.
39. Sherwin BB. Randomised clinical trials of combined androgen-androgen preparations: effects on sexual functioning. Fertil Steril 2002; 77(suppl. 4): 49-54. doi: 10.1016/S0015-0282(02)03002-9
40. Collins A, Landgren BM. Reproductive health, use of estrogens and experience of symptoms in postmenopausal women: a population based study. Maturitas 1994; 20: 101-11. doi: 10.1016/0378-5122(94)90005-1
41. Goldstat R, Briganti E, Tran J, Wolfe R, Davis SR. Transdermal testosterone therapy improves well being, mood and sexual function in premenopausal women. Menopause 2003; 10: 390-8. doi: 10.1097/01.GME.0000060256. 03945.20
42. Basson R. Female sexual response: the role of drugs in the management of sexual dysfunction. Obstet Gynecol 2001b; 98: 350-3. doi: 10.1016/S0029-7844(01) 01452-1
43. Davis SR. The effects of tibolone on mood and libido. Menopause 2002; 9: 162-70. doi: 10.1097/00042192-200205000-00004
44. Fourcroy JL. Female sexual dysfunction: potential for pharmacotherapy. Drugs 2003; 63: 1445-57. doi: 10.2165/00003495-200363140-00002
45. Kaplan SA, Reis RB, Kohn IJ, Ikeguchi EF, Laor E, Te AE, Martins ACP. Safety and efficiency of sildenafil in postmenopausal women with sexual dysfunction. Urology 1999; 53: 481-6. doi: 10.1016/S0090-4295(98)00633-5
46. Berman JR, Berman LA, Toler SM, Gill J, Haughie S. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double blind, placebo controlled study. J Urol 2003; 170: 2333-8. doi: 10.1097/01.ju.0000090966.74607.34
47. Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL. A placebo controlled trial of bupropion SR as an antidote of SSRI induced sexual dysfunction. J Clin Psychiatry 2004; 65(1): 62-7.
48. Ginzburg R, Wong Y, Fader JS. Effect of bupropion on sexual function. Ann Pharmacother 2005; 39(12): 2096-9. doi: 10.1345/aph.1G275
49. Simon JA, Mazer NA, Wekselman K. Safety profile: transdermal testosterone treatment of women after oophorectomy. Obstet Gynecol 2001; 97: S10-1. doi: 10.1016/S0029-7844(01)01154-1
50. Simon JA, Nachtigal LE, Davis SR, Utian WH, Lucas JD, Braunstein GD. Obstet Gynecol 2004; 103: S64.
51. Alexander JL, Kotz K, Dennerstein L, Kutner SJ, Wallen K, Notelovitz M. The effects of menopausal hormone therapies on female sexual functioning: review of double-blind randomized controlled trials. Menopause 2004; 11(6): 749-795. doi: 10.1097/01.GME.0000142887.31811.97
52. Walton B, Thorton T. Female sexual dysfunction. Curr Womens Health Rep 2003; 3: 319-26.
53. Shen WW, Urosevich Z, Clayton DO. Sildenafil in the treatment of female sexual dysfunction induced by SSRI's. J Reprod Med 1999; 44(6): 535-42.
54. Nurnberg HG, et al. Sildenafil for selective reuptake inhibitor associated female sexual dysfunction (abstract) presented 155th Annual Meeting of the American Psychiatric Association, Philadelphia, PA, 2002.
55. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SAA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D. Effects of estrogens plus progestin on gynaecologic cancers and associated diagnostic procedures: The Women's Health Initiative Randomised Trial. JAMA 2003; 290: 1739-48. doi: 10.1001/jama.290.13.1739
56. Lobo RA. Evaluation of cardiovascular event rates with hormone therapy in healthy, early postmenopausal women: results from 2 large clinical trials. Arch Intern Med 2004; 164: 482-4. doi: 10.1001/archinte.164.5.482
57. Basson R. Are our definitions of women's desire, arousal and pain disorders too broad and our definition of orgasmic disorder too narrow? J Sex Marital Ther 2002; 28: 289-300. doi: 10.1080/00926230290001411
58. Laumann EO, Gagnon JH, Michael RT, Michaels S. The social organization of sexuality: sexual practices in the United States. Chicago, IL: University of Chicago Press; 1994.
59. Hisasue S, Kumamoto Y, Sato Y, Masumori N, Horita H, Kato R, Kobayashi K, Hashimoto K, Yamashita N, Itoh N. Prevalence of female sexual dysfunction symptoms and its relationship to quality of life: a Japanese female cohort study. Urology 2005; 65(1): 143-8. doi: 10.1016/j.urology.2004.08.003
60. Lobo RA. Treatment of postmenopausal women. Boston, MA: Lippincott; 1999.
61. Kerner I. She comes first. New York: Harper Collins; 2004.